People search for alternatives to these four drugs for three different reasons: cost, availability, or because the medication is not working or not tolerated. Those need different answers, and conflating them is how people end up on the wrong thing.
Switching Is a Clinical Decision
Every option below is a prescription medication with its own risks, contraindications and approved uses. Nothing here tells you what to switch to. Use it to know what exists so you can have a better conversation with a prescriber, and see the FDA's drug database for approved labelling.
First: Are These Four Actually Different?
| Brand | Active Ingredient | FDA-Approved For |
|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes |
| Wegovy | Semaglutide | Chronic weight management |
| Mounjaro | Tirzepatide | Type 2 diabetes |
| Zepbound | Tirzepatide | Chronic weight management, and obstructive sleep apnea in adults with obesity |
Ozempic and Wegovy share an active ingredient, as do Mounjaro and Zepbound. The pairs differ in approved indication and dosing.
This matters because the most common substitution is between the pairs. If your issue is that Ozempic is not covered for weight loss, the answer may be Wegovy rather than a different drug entirely. Our semaglutide versus tirzepatide comparison covers the clinical differences between the two molecules.
If Cost Is the Problem
This is the most common reason people look for alternatives, and it usually does not require changing medication at all. It requires changing where you buy it.
| Route | Published Price | Notes |
|---|---|---|
| Medicare GLP-1 Bridge Program | $50 per month | Wegovy, Zepbound KwikPen or Foundayo for eligible Part D members through 2027 |
| NovoCare Pharmacy Wegovy pill | $149 per month | FDA-approved oral semaglutide direct from the manufacturer |
| LillyDirect Zepbound 2.5 mg | $299 per month | FDA-approved tirzepatide direct from Eli Lilly |
| Manufacturer savings cards | As little as $25 | For eligible commercially insured patients, subject to caps |
| Compounded semaglutide | $99 to $199 per month | Not FDA-approved; quality depends on the compounding pharmacy |
Before switching medication over cost, check whether the same medication is cheaper elsewhere. Our [cost guide](/articles/glp1-cost-guide) works through this.
Oral Alternatives to Injections
If the injection itself is the barrier, FDA-approved oral GLP-1s now exist. The Wegovy pill, Rybelsus and Foundayo (orforglipron) are all approved oral options, and several providers prescribe them. Compounded oral and sublingual products also exist but are a different proposition entirely, which our oral GLP-1 guide explains in detail.
Non-GLP-1 Prescription Options
GLP-1s are not the only approved weight management medications, and they are not right for everyone. A prescriber may consider these instead:
Qsymia (phentermine-topiramate)
An oral combination for chronic weight management. Offered by MEDvidi and used at Medi-Weightloss .
Phentermine
A short-term appetite suppressant, available as Lomaira and Adipex-P. Used at Medi-Weightloss and offered by MEDvidi .
Orlistat (Xenical, Alli)
Works by reducing fat absorption rather than appetite. Offered by MEDvidi .
Metformin
Used off-label for weight in some contexts, and commonly prescribed for insulin resistance. Offered by MEDvidi .
Providers that carry a wide non-GLP-1 menu are worth knowing about precisely because they can prescribe something other than a GLP-1 if that is the better answer. MEDvidi has the broadest list we found. The Obesity Medicine Association publishes clinical background on the range of approved options.
If the Medication Is Not Working or Not Tolerated
This is the case where genuinely changing medication may be appropriate, and it is entirely a clinical conversation. Points worth raising with your prescriber:
- Whether your dose has been fully titrated, since effects differ substantially across the dose range
- Whether side effects might be managed rather than requiring a switch, covered in our side effects explainer
- Whether switching between semaglutide and tirzepatide is appropriate, since they act on different receptors
- Whether a slower titration schedule would help tolerability
- Whether microdosing is a reasonable option, offered formally by Precision Telemed , Fridays and WeightCare
- Whether a non-GLP-1 medication suits your situation better
Be Careful With Unapproved Products
Searches for alternatives surface a lot of supplements marketed as natural GLP-1 boosters, along with research-chemical peptides sold without prescriptions. These are not equivalent to prescription GLP-1 medication, are not evaluated for safety or effectiveness in this use, and in the case of research chemicals are not intended for human use at all. The FDA has warned about unapproved semaglutide products marketed for weight loss.
If Your Insurance Denied Coverage
A denial is not always the end. Ask whether your plan excludes weight-loss medication as a benefit category entirely, or whether it covers it subject to prior authorization, because those are different problems with different solutions. Providers that actively handle this include Klinic , which bills Medicare Part D and Medicaid, Midi Health , which is in-network with major carriers, and Zealthy , which pursues brand-name coverage and offers a compounded fallback if it fails. Our insurance, HSA and FSA guide covers the process.
The Retail Route
Before assuming a compounded alternative is the cheapest path, check retail. Sam's Club Pharmacy and Kroger Pharmacy publish eligible GLP-1s as low as $25 a month with insurance and around $149 self-pay for the oral formulation, with a $50 route for eligible Medicare members. That is an FDA-approved product at a price that now competes with compounded programmes. See our retail pharmacy comparison .
Supplements Are Not an Alternative
Products marketed as natural GLP-1s are not a substitute for the medications on this page. The best-evidenced of them, Calocurb , publishes an average 8.3lb loss over six months; semaglutide trials report around 15 percent of body weight and tirzepatide around 21. Several also cost more per month than compounded semaglutide. Our supplement evidence review explains the gap.
Frequently Asked Questions
What is the closest alternative to Ozempic?
Wegovy contains the same active ingredient, semaglutide, but is approved for chronic weight management rather than type 2 diabetes. If your issue is coverage for weight loss specifically, that swap is often the relevant one to discuss with your prescriber.
Is there a cheaper alternative to Zepbound?
Often the same drug is cheaper elsewhere. LillyDirect publishes Zepbound from $299 a month at the starting strength, and eligible Medicare Part D members can access the Zepbound KwikPen for $50 a month through the Bridge Program. Compounded tirzepatide is cheaper still but is not FDA-approved.
What can I take instead of a GLP-1?
Approved non-GLP-1 options include Contrave, Qsymia, phentermine and orlistat, and Saxenda is a daily GLP-1 that differs from the weekly injections. Which is appropriate is a clinical decision. MEDvidi carries the widest published menu.
Are natural Ozempic alternatives real?
Supplements marketed as natural GLP-1 boosters are not equivalent to prescription GLP-1 medication and are not evaluated for this use. The FDA has issued warnings about unapproved products marketed for weight loss.
Can I switch from semaglutide to tirzepatide?
That is a clinical decision for your prescriber. They act on different receptors, tirzepatide targeting both GLP-1 and GIP, and dosing schedules differ. See our full comparison .
What if my medication is out of stock?
Availability has improved substantially since the shortage years, and manufacturer direct channels such as LillyDirect and NovoCare Pharmacy dispense their own products. Ask your prescriber about routing your prescription there.
Medical Disclaimer
This article is general information, not medical advice. GLP-1 medications are prescription drugs with real risks and contraindications, and only a licensed clinician who knows your history can decide whether one is appropriate for you. Prices, programs and policies described here reflect what providers published at the time of writing and change frequently; verify everything directly before enrolling. Read our full medical disclaimer.
Last reviewed: August 25, 2026